Reflex sympathetic dystrophy and neurotransmitters;Algodystrophie et neuromédiateurs

Revue du Rhumatisme (Edition Francaise)

Volumn 70, Issue 1, 2003, Pages 16-21

  Pham, Thao ^a   Lafforgue, Pierre ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Algodystrophy; Neurogenic inflammation; Neurotransmitter; Reflex sympathetic dystrophy; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CATECHOLAMINE; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTRANSMITTER; SUBSTANCE P;

ALGODYSTROPHY; AUTONOMIC DENERVATION; BLOOD VESSEL PERMEABILITY; COMPLEX REGIONAL PAIN SYNDROME TYPE I; EFFERENT NERVE; HUMAN; NERVE EXCITABILITY; NERVE FIBER; NERVE INJURY; NEUROGENIC INFLAMMATION; PAIN THRESHOLD; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN SECRETION; REVIEW; SENSITIVITY ANALYSIS; SENSORY NERVE; SYMPATHECTOMY; SYMPATHETIC NERVE; SYMPATHETIC TONE; THEORY; VASODILATATION;

EID: 11244275729     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(02)00006-6     Document Type: Review

References (86)

1. Pawl RP. Controversies surrounding reflex sympathetic dystrophy: a review article. Curr Rev Pain 2000;4:259-67.
2. Marshall AT, Crisp AJ. Reflex sympathetic dystrophy. Rheumatology 2000;39:692-5.
3. Leriche R. De la causalgie envisagée comme une névrite du sympathique et de son traitement par la dénudation et de l'excision des plexus nerveux péri-artériels. Presse Méd 1916;24:178-80.
4. Kurvers AJM. Reflex sympathetic dystrophy: facts and hypotheses. Vascular Medecine 1998;3:207-14.
5. Schürmann M, Gradl G, Andress HJ, Fürst H, Schildberg FW. Assessment of peripheral sympathetic nervous function for diagnosing early post-traumatic complex regional pain syndrome type I. Pain 1999;80:149-59.
6. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993;342:1012-6.
7. Leriche R. Œdème dur post-traumatique de la main avec impotence fonctionnelle complète, Transformation soudaine 5 h après sympathectomie humérale. Lyon Chir 1923;20:814-8.
8. Jänig W. Experimental approach to reflex sympathetic dystrophy and related syndromes. Pain 1991;46:241-5.
9. Kurvers HA, Jacobs MJ, Beuk RJ, van den Wildenberg FA, Kitslaar PJ, Slaaf DW, et al. Reflex sympathetic dystrophy: evolution of microcirculatory disturbances in time. Pain 1995;60:333-40.
10. Kurvers HA, Jacobs MJ, Beuk RJ, van den Wildenberg FA, Kitslaar PJ, Slaaf DW, et al. The spinal component to skin blood flow abnormalities in reflex sympathetic dystrophy. Arch Neurol 1996;53:58-65.
11. Rosen L, Ostergren J, Fagrell B, Stranden E. Skin microvasular circulation in the sympathetic dystrophies evaluated by video photometric capillaroscopy and laser Doppler fluxmetry. Eur J Clin Invest 1988;18:305-8.
12. Christensen K, Henriksen O. The reflex sympathetic dystrophy syndrome, An experimental study of sympathetic reflex control of subcutaneous blood flow in the hand. Scand J Rheumatol 1983;12:263-7.
13. Kurvers HA, Jacobs MJ, Beuk RJ, van den Wildenberg FA, Kitslaar PJ, Slaaf DW, et al. Reflex sympathetic dystrophy: result of autonomic denervation? Clin Sci (Colch) 1994;87:663-9.
14. Hassan AAK, Tooke JE. Mechanism of the postural vasoconstrict response in the human foot. Clin Sci 1998;75:379-87.
15. Baron R, Maier C. Reflex sympathetic dystrophy: skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy. Pain 1996;67:317-26.
16. Casale R, Elam M. Normal sympathetic nerve activity in a reflex sympathetic dystrophy with marked skin vasoconstriction. J Auton Nerv Syst 1992;41:215-20.
17. Clinchot DM, Lorch F. Sympathetic skin response in patients with reflex sympathetic dystrophy. Am J Phys Med Rehabil 1996;75:252-6.
18. Van der Laan L, ter Laak HJ, Gabreels-Festen A, Gabreels F, Gorisn RJA. Complex regional pain syndrome type 1: pathology of skeletal muscle and peripheral nerve. Neurology 1998;51:46-51.
19. Mathias CJ, Christensen NJ, Corbett JL, Frankel HL, Spalding JM. Plasma catecholamines during paroxysmal neurogenic hyper-tension in quadriplegic man. Circ Res 1976;39:204-9.
20. Polinsky RJ, Kopin IJ, Ebert MH, Weise V. Pharmacologic distinction of different orthostatic hypotensive syndromes. Neurology 1981;31:1-7.
21. Goldstein DS, Bonner RF, Zimlichman R, Zahn TP, Cannon RO, Rosing DR, et al. Indexes of sympathetic vascular innervation in sympathectomized patients. J Auton Nerv Syst 1986;15:309-18.
22. Wallin BG, Sundlof G, Erikksson BM, Dominiak P, Grobecker H, Linblad LE. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 1981;111:69-73.
23. Bennet GJ. An animal model of neuropathic pain. Muscle Nerve 1993;16:1040-8.
24. Bennet GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
25. Attal NJF, Kayser V, Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain 1990;41:235-51.
26. Kingery WS, Castellote JM, Wang EE. A loose ligature-induced mononeuropathy produces hyper-algesias mediated by both the injured sciatic nerve and the adjacent saphenous nerve. Pain 1993;55:297-304.
27. Raja SN, Choi Y, Asano Y, Holmes C, Goldstein DS. Arteriovenous differences in plasma concentrations of catechols in rats with neuropathic pain. Anesthesiology 1995;83:1000-8.
28. Goldstein DS, Tack C, Li ST. Sympathetic innervation and function in reflex sympathetic dystrophy. Ann Neurol 2000;48:49-59.
29. Harden RN, Duc TA, Williams TR, Coley D, Cate JC, Gracely RH. Norepinephrine and epinephrine levels in affected versus unaffected limbs in sympathetically maintained pain. Clin J Pain 1994;10:324-30.
30. Drummond PD, Finch PM, Smythe GA. Reflex sympathetic dystrophy: the significance of differing plasma catecholamine concentrations in affected and unaffected limbs. Brain 1991;114:2025-36.
31. Pham T, Guieu R, Legré V, Lafforgue P. Reflex sympathetic dystrophy: plasma catecholamine levels in affected and unaffected limbs. Arthritis Rheum 2001;44(Supp. 9):S73.
32. Drummond PD, Finch PM, Edvinsson L, Goadsby PJ. Plasma neuropeptide Y in symptomatic limb of patients with causalgic pain. Clin Auton Res 1994;4:113-6.
33. Hogestatt ED, Hammarstrom LE, Anderson KE, Holmin T. Contractile effects of various vasoactive agents in small rat portal veins and hepatic arteries and the influence of sympathetic denervation on the noradrenaline response. Acta Physiol Scand 1986;128:309-15.
34. Arnold JMO, Teasell RW, MacLeod AP, Brown JE, Carruthers SG. Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med 1993;118:619-21.
35. Drummond PD, Skipworth S, Finch PM. Alpha 1-adrenoceptors in normal and hyperalgesic human skin. Clin Sci 1996;91:73-7.
36. Drummond PD. Mechanism of complex regional pain syndrome: no longer excessive sympathetic outflow? Lancet 2001;358:168-9.
37. Homans J. Minor causalgia: a hyper-esthesic neurovascular syndrome. N Engl J Med 1940;222:870-4.
38. Leriche R. La chirurgie de la douleur. Paris: Masson; 1949.
39. Olson Jr WL. Perineal reflex sympathetic dystrophy treated with bilateral lumbar sympathectomy. Ann Intern Med 1990;113:633-4.
40. Schott GD. Visceral afferents: their contribution to "sympathetic dependant" pain. Brain 1994;117:397-413.
41. Perrot S, Guilbaud G. Physiopathologie de la douleur articulaire. Rev Rhum 1996;63:569-76.
42. Berthelot JM, Glemarec J, Guillot P, Maugars Y, Prost A. Algodystrophies-Causalgies: Nouveaux concepts nosologiques, physiologiques et pathogéniques, L'hypothèse d'un fonctionnement de la voie efférente du sympathique était-elle une fausse piste ? Rev Rhum (Ed Fr) 1997;64:562-73.
43. Schaible HG, Schmidt RF. Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J Neurophysiol 1985;54:1109-22.
44. Schott GD. An unsympathetic view of pain. Lancet 1995;345:634-6.
45. Schürmann M, Gradl G, Fürst H. A standardized beside test for assessment of peripheral sympathetic nervous function using laser doppler fluwmetry. Microvasc Res 1996;52:157-70.
46. Birklein F, Claus D, Riedl B, Neundörfer B, Handwerker HO. Effects of cutaneous histamine application in patients with sympathetic reflex dystrophy. Muscle Nerve 1997;20:1389-95.
47. Roberts WJ. A hypothesis on the physiological basis for causalgia and related pain. Pain 1986;24:297-311.
48. Kidd BL, Mapp PI, Blake DR, Gibson SJ, Polak JM. Neurogenic influences in arthritis. Ann Rheum Dis 1990;49:649-52.
49. Snyder SH. Peptide neurotransmitters with possible involvement in pain perception. In: Bonica JJ, editor. Pain. New York: Raven Press; 1980. p. 233-43.
50. Burnstock G. Regulation of local blood flow by neurohumeral substances released from perivascular nerves and endothelial cells. Acta Physiol Scand 1988;133(Supp. 571):53-9.
51. Lembeck F, Holzer P. Substance P as a neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 1979;310:175-83.
52. Brain SD, Williams TJ, Tippins JR, Morris HR, Macintyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985;313:54-6.
53. Brain SD, Tippins JR, Morris HR, Macintyre I, Williams TJ. Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol 1986;87:533-6.
54. Lewis D. Treatment of causalgia: results of intraneural injections of 60% alcohol. JAMA 1920;74:1-4.
55. Coderre TJ, Basbaum AL, Levine JD. Neural control of vascular permeability: interactions between primary afferents, mast cells and sympathetic efferents. J Neurophysiol 1989;62:48-58.
56. Kenins P. Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation. Neurosci Lett 1981;25:137-41.
57. Snijdelaar DG, Dirksen R, Slappendel R, Crul BJP. Substance P. Eur J Pain 2000;4:121-35.
58. Vaught JL. Substance P, antagonists and analgesia: a review of hypothesis. Life Sci 1988;43:1419-31.
59. Anichini M, Cesaretti S, Lepori M, Maddalibongi S, Maresca M, Zoppi M. La substance P dans le sérum des patients souffrant de polyarthrite rhumatoïde. Rev Rhum 1997;64:19-22.
60. Nichols ML, Allen BJ, Rogers SD, Ghilardi JR, Honore P, Luger NM, et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999;286:1558-61.
61. Khalil Z, Helme RD. Serotonin modulates substance P-induced plasma extravasation and vasodilatation in rat skin by an action through capsaicin-sensitive primary afferent nerves. Brain Res 1990;527:292-8.
62. Benyon RC, Lowman MA, Church MK. Human skin mast cells: their dispersion, purification and secretory characterization. J Immunol 1987;138:861-7.
63. Rumsfield JA, West DP. Topical capsaicin in dermatologic and peripheral pain disorders. DICP 1991;25:381-7.
64. Szallasi A, Blumberg PM. Vanilloid receptors: new insights enhance potential as a therapeutic target. Pain 1996;68:195-208.
65. Nolano M, Simone DA, Wendelschafer-Crabb G, Kennedy WR. Decrease sensation and loss of epidermal nerve fibers following repeated topical application of capsaicin in humans. Soc Neurosci Abstr 1996;22:1558-61.
66. Winter J, Bevan S, Campbell EA. Capsaicin and pain mechanisms. Br J Anaesth 1995;75:157-68.
67. Kimura S, Okada M, Sugita Y, Kanazawa I, Munekata E. Novel neuropeptides, neurokinin A and B, isolated from porcine spinal cord. Proc Jpn Acad 1983;59B:101-4.
68. Yu LC, Hansson P, Lundebergn T. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats. Brain Res 1994;653:233-40.
69. Bove GM, Light AR. Calcitonin gene-related peptide and peripherin immunoreactivity in nerve sheaths. Somatosens. Mot Res 1995;12:49-57.
70. Brain SD, Hughes SR, Cambridge H, O'Driscoll G. The CGRP (contribution of calcitonin gene-related peptide) to neurogenic vasodilator responses. Agents Action 1993;38:C19-21.
71. Onuoha GN, Kaya Alpar E. Calcitonin gene-related peptide and others neuropeptides in the plasma of patients with soft tissue injury. Life Sci 1999;65:1351-8.
72. Pincelli C, Fantini F, Giannetti A. Neuropeptides and skin inflammation. Dermatology 1993;187:153-8.
73. Oku R, Satoh M, Fujii N, Otaka A, Yajima H, Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res 1987;403:350-4.
74. Blair SJ, Chinthagada M, Hoppenstehdt D, Kijowski R, Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belgica 1998;64:448-50.
75. Dray A, Perkins M. Bradykinin and inflammatory pain trend in neuropharmacological sciences. Trends in Neuropharmacological Sciences 1993;16:99-103.
76. Merskey H. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986;3:S215-21.
77. McMahon SB, Dmitrieva N, Koltzenburg M. Visceral pain. Br J Anaesth 1995;75:132-44.
78. Woolf CJ. Somatic pain-pathogenesis and prevention. Br J Anaesth 1995;75:169-76.
79. Nilsson SFE, Mäepea O. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide HI (PHI) in the rabbit and the cat. Acta Physiol Scand 1987;129:17-26.
80. Vaalasti A, Tainio H, Rechardt L. Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in the nerves of human axillary sweat gland. J Invest Dermatol 1985;85:246-8.
81. Chard MD, Ghatei MA, Crisp AJ. Vasoactive intestinal polypeptide in algodystrophy. Br J Rheumatol 1990;29:489-90.
82. Ekblad E, Edvinsson E, Wahlestedt C, Uddman R, Häkanson R, Sundler F. Neuropeptide Y co-exists and co-operate with noradrenaline in perivacular nerve fibres. Regul Pept 1984;8:225-35.
83. Balasubramaniam A. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 1997;18:445-57.
84. C. Masson, M. Audran, Algodystrophie, Encycl. Méd. Chir., Appareil locomoteur, Vol. 14-286-A-10, Paris: Elsevier, 1999 13 p.
85. Wasner G, Heckmann K, Maier C, Baron R. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I). Arch Neurol 1999;56:613-20.
86. Wasner G, Schattschneider J, Heckmann K, Baron R. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001;124:587-99.